About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment
Advances in screening technologies have enabledthe identification of interactive gene combinations, enabling the developmentof lead candidates that leverage the principle of synthetic lethality forcancer treatment
To order this 485+ page report, which features 195+figures and 200+ tables, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-/267.html
The USD 8 billion (by 2030) financialopportunity within the synthetic lethality-based drugs and targets market hasbeen analyzed across the following segments:
§ Type of molecule
§ Small Molecule
§ Biologic
§ Target diseaseindication
§ Breast Cancer
§ Colorectal Cancer
§ Fallopian Tube Cancer
§ Gastric Cancer
§ Head and Neck Cancer
§ Lung Cancer
§ Ovarian Cancer
§ Peritoneal Cancer
§ Others
§ Type of synlet target
§ APE1 / Ref-1
§ Chk1
§ GLS1
§ PARP
§ Pol θ
§ PP2A
§ Wee1
§ Route ofadministration
§ Oral
§ Intravenous
§ Key geographicalregions
§ North America
§ Europe
§ Asia Pacific
- Rest of the World
The https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html, report features the followingcompanies, which we identified to be key players in this domain:
§ AbbVie
§ AstraZeneca
§ AtlasMedx
§ BeiGene
§ Chordia Therapeutics
§ Clovis Oncology
§ GlaxoSmithKline
§ IDEAYA Biosciences
§ Mission Therapeutics
§ Pfizer
§ Repare Therapeutics
§ Sierra Oncology
§ SyntheXLabs
Table of Contents
1. Preface
2. Executive Summary
3. Introduction toDNA Damage and Repair Systems
4. Introduction to Synthetic Lethality
5. Market Overview
6. Company Profiles
7. Emerging Trends on Social Media
8. Publication Analysis
9. Abstract Analysis
10. Academic Grants Analysis
11. Funding and Investment Analysis
12. Target Benchmark Analysis
13. Role of Companion Diagnostics in Synthetic Lethality
14. Market Forecast
15. Concluding Remarks
16. Executive Insights
17. Appendix 1: Tabulated Data
18. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
